作者
Shanshan Suo,Shu Sun,Le Xuan Truong Nguyen,Jiejing Qian,Fenglin Li,Dandan Zhao,Wenjuan Yu,Yinjun Lou,Hong‐Hu Zhu,Hongyan Tong,Min Yang,Xin Huang,Shuqi Zhao,Jun-Jing Qiao,Liang Chen,Huafeng Wang,Yi Zhang,Xiang Zhang,Dinh Hoa Hoang,Chen Fang,HyunJun Kang,Melissa Valerio,Jie Sun,Lucy Ghoda,Ling Li,Guido Marcucci,Bin Zhang,Jie Jin
摘要
Early T cell precursor acute lymphoblastic leukemia (ETP-ALL) is a distinct subtype of T-ALL with a poor prognosis. To find a cure, we examined the synergistic effect of homoharringtonine (HHT) in combination with the BCL-2 inhibitor venetoclax (VEN) in ETP-ALL.